Platform Migration Library Guide: Streamlining Your Transition

In December 2023 Taylor & Francis acquired 32 renowned peer reviewed journals from former biomedical publisher Future Science Group. These journals complement the existing range of over 340 Taylor & Francis medical and healthcare journals.

The way content from the previous publisher can be accessed has changed. From May 24, 2024, former Future Science Group platforms will close. Journals that were formerly hosted on these platforms will now have a new home at Taylor & Francis Online.

To support a smooth transition for you and your library users we have included essential information and steps you need to take to make sure ongoing access to these titles.

Redirects

Permanent 301 redirects will be set up at the title level starting on May 24. This will allow users to be easily redirected from the former publisher’s websites to their new locations on Taylor & Francis Online.

Managing an account on Taylor & Francis Online

A nominated person from your institution will need to be registered as an account administrator on Taylor & Francis Online in order to manage your organization’s account.

We have information and support available to help with this: How to register

Checking access is correct

We have been working hard to make sure your access is transferred accurately to Taylor & Francis Online. Please do take some time to check it matches that on the former Future Science Group platforms.

Do we have the right IP range for your institution?

Please do also take some time to check that we have the right IP range for your institution on Taylor & Francis Online.

Support with checking and adding IP addresses is available here: How do I update my institution’s IP ranges?

Usage statistics

Taylor & Francis will retain limited access to usage statistics from the former Future Science Group platforms until May 2026 for calendar years 2022-24. This can be provided to on request, but libraries will not be available to self-serve this data after the end of May 2024.

Linking and discovery tools

KBART holding files will be made available to the following vendors: ExLibris – Alma; Summon/360/Intota; SFX; TDNet; Rialto; OCLC. They will also be available for you to download from Taylor & Francis Online. Further support is available here: How do I set up my link resolver?

DOIs and CrossRef linking will point to Taylor & Francis Online from 16th May 2024.

We are also working with Google Scholar to point users to Taylor & Francis Online.

Further help

List of journal titles

Below is a list of the journal titles with information including their new home on Taylor & Francis Online. Please note, the FSG links will close and redirect to Taylor & Francis Online at the end of May 2024.

Journal acronymJournal nameModelFSG linkT&F link
BMMBiomarkers in MedicineHybridhttps://www.futuremedicine.com/journal/bmmhttps://www.tandfonline.com/journals/ibmm20
EPIEpigenomicsHybridhttps://www.futuremedicine.com/journal/epihttps://www.tandfonline.com/journals/iepi20
FCAFuture CardiologyHybridhttps://www.futuremedicine.com/journal/fcahttps://www.tandfonline.com/journals/ifca20
FMBFuture MicrobiologyHybridhttps://www.futuremedicine.com/journal/fmbhttps://www.tandfonline.com/journals/ifmb20
FONFuture OncologyHybridhttps://www.futuremedicine.com/journal/fonhttps://www.tandfonline.com/journals/ifon20
FVLFuture VirologyHybridhttps://www.futuremedicine.com/journal/fvlhttps://www.tandfonline.com/journals/ifvl20
IMTImmunotherapyHybridhttps://www.futuremedicine.com/journal/imthttps://www.tandfonline.com/journals/iimy20
NNMNanomedicineHybridhttps://www.futuremedicine.com/journal/nnmhttps://www.tandfonline.com/journals/innm20
NMTNeurodegenerative Disease ManagementHybridhttps://www.futuremedicine.com/journal/nmthttps://www.tandfonline.com/journals/inmt20
PMTPain ManagementHybridhttps://www.futuremedicine.com/journal/pmthttps://www.tandfonline.com/journals/inmt20
PMEPersonalized MedicineHybridhttps://www.futuremedicine.com/journal/pmehttps://www.tandfonline.com/journals/ipme20
PGSPharmacogenomicsHybridhttps://www.futuremedicine.com/journal/pgshttps://www.tandfonline.com/journals/ipgs20
RMERegenerative MedicineHybridhttps://www.futuremedicine.com/journal/rmehttps://www.tandfonline.com/journals/irme20
FNLFuture NeurologyOAhttps://www.futuremedicine.com/journal/fnlhttps://www.tandfonline.com/journals/ifnl20
CRCColorectal CancerOAhttps://www.futuremedicine.com/journal/crchttps://www.tandfonline.com/journals/icrc20
MMTMelanoma ManagementOAhttps://www.futuremedicine.com/journal/mmthttps://www.tandfonline.com/journals/immt20
LMTLung Cancer ManagementOAhttps://www.futuremedicine.com/journal/lmthttps://www.tandfonline.com/journals/ilmt20
CNSCNS OncologyOAhttps://www.futuremedicine.com/journal/cnshttps://www.tandfonline.com/journals/icns20
HEPHepatic OncologyOAhttps://www.futuremedicine.com/journal/hephttps://www.tandfonline.com/journals/ihep20
IJEInternational Journal of Endocrine Oncology [rename coming]OAhttps://www.futuremedicine.com/journal/ijehttps://www.tandfonline.com/journals/iije20
TDETherapeutic DeliveryHybridhttps://www.future-science.com/journal/tdehttps://www.tandfonline.com/journals/itde20
BIOBioanalysisHybridhttps://www.future-science.com/journal/biohttps://www.tandfonline.com/journals/ibio20
FMCFuture Medicinal ChemistryHybridhttps://www.future-science.com/journal/fmchttps://www.tandfonline.com/journals/ifmc20
PPAPharmaceutical Patent AnalystHybridhttps://www.future-science.com/journal/ppahttps://www.tandfonline.com/journals/ippa20
FDDFuture Drug DiscoveryOAhttps://www.future-science.com/journal/fddhttps://www.tandfonline.com/journals/ifdd20
BTNBioTechniquesOAhttps://www.future-science.com/journal/btnhttps://www.tandfonline.com/journals/ibtn20
FSOAFuture Science OAOAhttps://www.future-science.com/journal/fsoahttps://www.tandfonline.com/journals/ifso20
FRDFuture Rare DiseasesOAhttps://www.futuremedicine.com/journal/frdhttps://www.tandfonline.com/journals/ifrd20

Below is the list of ceasing journals – content from these journals will be available on Taylor & Francis Online.

Information on eBooks

Frequently asked questions